FDA
label_change
· 2015-12-16
FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
The FDA approved a supplemental application for AMNESTEEM (isotretinoin) from Mylan Pharmaceuticals, indicating a labeling-related update for this generic produ…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMNESTEEM (ISOTRETINOIN)